Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke

Area of Science:

• Regenerative medicine
• Neuroscience
• Stem cell therapy

Background:

• Cerebral infarction, a central nervous system disease, lacks effective treatments.
• Regenerative medicine offers potential by restoring organ and tissue functions.
• Somatic stem cell therapies are being investigated for neurological disorders.

Purpose of the Study:

• To review the current state of dental pulp stem cell therapy for acute cerebral ischemia.
• To explore the therapeutic mechanisms and clinical trial progress of this treatment.
• To discuss future prospects for stem cell-based regenerative medicine in stroke treatment.

Main Methods:

• Review of basic research on dental pulp stem cells.
• Analysis of therapeutic mechanisms in experimental models of ischemic brain injury.
• Examination of ongoing first-in-human clinical trials in Japan.

Main Results:

• Experimental studies indicate cellular therapy with human dental pulp stem cells is a viable strategy for ischemic brain injury.
• Clinical trials are actively investigating the efficacy of this approach in patients with acute cerebral ischemia.
• Mesenchymal stem cell therapy is a key area of research for cerebral infarction.

Conclusions:

• Dental pulp stem cell therapy presents a promising avenue for treating acute cerebral ischemia.
• Further research and clinical trials are crucial to establish the effectiveness and safety of this regenerative medicine approach.
• Somatic stem cell therapy holds significant potential for addressing unmet needs in treating central nervous system diseases like stroke.